These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2217026)

  • 1. Metyrapone-induced alopecia.
    Harries-Jones R; Overstall P
    Postgrad Med J; 1990 Jul; 66(777):584. PubMed ID: 2217026
    [No Abstract]   [Full Text] [Related]  

  • 2. Alopecia associated with long-term metyrapone use.
    Harris PL
    Clin Pharm; 1986 Jan; 5(1):66-8. PubMed ID: 3004800
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent alopecia induced by vismodegib.
    Alkeraye S; Maire C; Desmedt E; Templier C; Mortier L
    Br J Dermatol; 2015 Jun; 172(6):1671-1672. PubMed ID: 25546344
    [No Abstract]   [Full Text] [Related]  

  • 4. Alopecia associated with ritonavir-boosted atazanavir therapy.
    Torres HA; Barnett BJ; Arduino RC
    AIDS; 2007 Jun; 21(10):1391-2. PubMed ID: 17545728
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful control of Cushing's disease in the elderly with long term metyrapone.
    Donckier J; Burrin JM; Ramsay ID; Joplin GF
    Postgrad Med J; 1986 Aug; 62(730):727-30. PubMed ID: 3022270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recovery of Cushing syndrome revealing McCune-Albright syndrome].
    Halioui-Louhaichi S; Dridi Y; Azzabi O; Selmi I; Fetni I; Siala N; Maherzi A
    Arch Pediatr; 2016 Jan; 23(1):61-5. PubMed ID: 26552628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible cutaneous side effects of vismodegib treatment.
    Kwong B; Danial C; Liu A; Chun KA; Chang AL
    Cutis; 2017 Mar; 99(3):E19-E20. PubMed ID: 28398426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cushing's syndrome: metyrapone therapy as a preparation for selective trans-sphenoidal adenomectomy].
    Zgliczyński S
    Endokrynol Pol; 1982; 33(4-6):285-94. PubMed ID: 7185571
    [No Abstract]   [Full Text] [Related]  

  • 10. Metyrapone for Cushing's syndrome.
    Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
    Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
    Halioui-Louhaichi S; Azzabi O; Nefzi L; Ben Hariz M; Ben Mrad N; Ben Ammar B; Maherzi A
    Arch Pediatr; 2005 Jul; 12(7):1120-3. PubMed ID: 15964528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of Cushing's disease with sudden remission after an episode of hysteria or administration of reserpine-metyrapone (author's transl)].
    Obara T; Nakagawa K; Keimatsu M; Ito Y; Kunita H
    Nihon Naika Gakkai Zasshi; 1976 Sep; 65(9):906-12. PubMed ID: 1033973
    [No Abstract]   [Full Text] [Related]  

  • 13. Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
    Claps M; Cerri S; Grisanti S; Lazzari B; Ferrari V; Roca E; Perotti P; Terzolo M; Sigala S; Berruti A
    Endocrine; 2018 Jul; 61(1):169-172. PubMed ID: 29019062
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pituitary reactions to adrenalectomy for Cushing's syndrome and to the administration of SU 4885].
    ROBEL P
    Probl Actuels Endocrinol Nutr; 1961; 5(3):215-21. PubMed ID: 14492709
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome.
    Gillis D; Rösler A; Hannon TS; Koplewitz BZ; Hirsch HJ
    J Pediatr; 2008 Jun; 152(6):882-4, 884.e1-4. PubMed ID: 18492536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical case of alcohol-induced Cushingoid syndrome.
    Jenkins RM; Page MM
    Br Med J (Clin Res Ed); 1981 Apr; 282(6270):1117-8. PubMed ID: 6786459
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of diphenine on the functional state of the adrenal cortex in patients with Itsenko-Cushing disease].
    Starkova NT; Marova EI; Lemesheva SN; Goncharova VN; Atamanova TM
    Probl Endokrinol (Mosk); 1972; 18(6):35-8. PubMed ID: 4654765
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful metyrapone therapy of the ectopic ACTH syndrome.
    Coll R; Horner I; Kraiem Z; Gafni J
    Arch Intern Med; 1968 Jun; 121(6):549-53. PubMed ID: 4297368
    [No Abstract]   [Full Text] [Related]  

  • 19. Metyrapone in long-term management of Cushing's disease.
    Jeffcoate WJ; Rees LH; Tomlin S; Jones AE; Edwards CR; Besser GM
    Br Med J; 1977 Jul; 2(6081):215-7. PubMed ID: 195666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary therapy for Cushing's disease with metyrapone.
    Dickstein G; Lahav M; Shen-Orr Z; Edoute Y; Barzilai D
    JAMA; 1986 Mar; 255(9):1167-9. PubMed ID: 3003415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.